Cargando…
Rational use of mucoactive medications to treat pediatric airway disease
Many airway diseases in children, notably bronchiolitis, cystic fibrosis (CF), non-CF bronchiectasis including primary ciliary dyskinesia, pneumonia, and severe asthma are associated with retention of airway secretions. Medications to improve secretions clearance, the mucoactive medications, are emp...
Autores principales: | Linssen, R.S.N., Ma, J., Bem, R.A., Rubin, B.K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297155/ https://www.ncbi.nlm.nih.gov/pubmed/32653467 http://dx.doi.org/10.1016/j.prrv.2020.06.007 |
Ejemplares similares
-
Identification of dendritic cells, B cell and T cell subsets in Tasmanian devil lymphoid tissue; evidence for poor immune cell infiltration into devil facial tumors
por: Howson, Lauren J., et al.
Publicado: (2014) -
Mucoactive Agents in the Therapy of Upper Respiratory Airways Infections: Fair to Describe Them Just as Mucoactive?
por: Scaglione, Francesco, et al.
Publicado: (2019) -
Redox regulation of motile cilia in airway disease
por: Price, Michael E., et al.
Publicado: (2019) -
Modeling pediatric medulloblastoma
por: Roussel, Martine F., et al.
Publicado: (2019) -
Pediatric Acute Lung Injury and Sepsis Investigators (PALISI): Evolution of an Investigator-Initiated Research Network
por: Randolph, Adrienne G., et al.
Publicado: (2022)